Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro
Repurposing of currently available drugs is a valuable strategy to tackle the consequences of COVID-19. Recently, several studies have investigated the effect of psychoactive drugs on SARS-CoV-2 in cell culture models as well as in clinical practice. Our aim was to expand these studies and test some...
Main Authors: | Senem Merve Fred, Suvi Kuivanen, Hasan Ugurlu, Plinio Cabrera Casarotto, Lev Levanov, Kalle Saksela, Olli Vapalahti, Eero Castrén |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.755600/full |
Similar Items
-
Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant
by: Ravi Kant, et al.
Published: (2021-11-01) -
Carbon supported ternary layered double hydroxide nanocomposite for Fluoxetine removal and subsequent utilization of spent adsorbent as antidepressant
by: Samar M. Mahgoub, et al.
Published: (2024-02-01) -
Effect of fluoxetine on some cognitive functions of patients of depression
by: Jaykaran, et al.
Published: (2009-01-01) -
ClusTRace, a bioinformatic pipeline for analyzing clusters in virus phylogenies
by: Ilya Plyusnin, et al.
Published: (2022-05-01) -
HAVoC, a bioinformatic pipeline for reference-based consensus assembly and lineage assignment for SARS-CoV-2 sequences
by: Phuoc Thien Truong Nguyen, et al.
Published: (2021-07-01)